106 results
424B5
VBIV
VBI Vaccines Inc.
11 Apr 24
Prospectus supplement for primary offering
9:06am
to commercialization, marketing, manufacturing capabilities and strategy;
our ability to retain and maintain a good relationship with our current employees, and our … our plans related to commercialization, marketing, manufacturing capabilities and strategy;
ii
our ability to retain and maintain a good
8-K
EX-99.1
VBIV
VBI Vaccines Inc.
14 Nov 23
VBI Vaccines Reports Third Quarter 2023 Financial Results
4:07pm
deployment strategy of our U.S. commercial field force, and a reduction in activity-based commercial expenses related to PreHevbrio.
Net Cash Used in Operating
8-K
EX-99.1
vyxolkn
14 Aug 23
VBI Vaccines Reports Second Quarter 2023 Financial Results
8:00am
424B5
oldf4ijt
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
2zivnbx
7 Jul 23
Prospectus supplement for primary offering
5:20pm
424B5
7uskg
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
3h71irjaz5ax
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-99.1
aho7e
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
8-K
EX-99.1
551cjv9ngh w7iii
6 Dec 22
Entry into a Material Definitive Agreement
9:25am